Home Drug Codes J Codes J9071 · Cyclophosphamide
Updated July 1st, 2026

Cyclophosphamide J Code: J9071

Injection, cyclophosphamide (auromedics), 5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9071, effective October 1, 2026: $0.471 per HCPCS billing unit, down 3.9% from $0.49. From CMS's final file.

?
Medicare Payment Limit ?
$0.49
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$0.49
/ HCPCS billing unit · APC 9203
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
5
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, cyclophosphamide (auromedics), 5 mg
HCPCS Added Date April 1, 2022
Manufacturer Eugia US
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Multi-Dose
Dosage Form Injection

About Cyclophosphamide

Cyclophosphamide is a medication aligned to the HCPCS J Code: J9071 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Eugia US.

According to CMS Drug Use Information: Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
55150-0270-01 Cyclophosphamide Eugia Us Llc 100 500 MG / 2.5 ML
55150-0270-99 Cyclophosphamide Eugia Us Llc 100 500 MG / 2.5 ML
55150-0271-01 Cyclophosphamide Eugia Us Llc 200 cycloPHOSphamide Intra venous Solution … Login for More
55150-0271-99 Cyclophosphamide Eugia Us Llc 200 1000 MG / 5 ML
55150-0272-01 Cyclophosphamide Eugia Us Llc 400 2000 MG / 10 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Cyclophosphamide Pricing & Reimbursement

J9071 Private Payer Reimbursement
$1.25 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Cyclophosphamide 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9071 Eugia US Cyclophosphamide Injection, cyclophosphamide (auromedics), 5 mg
J9072 Avyxa Pharma Cyclophosphamide Injection, cyclophosphamide (frindovyx), 5 mg
J9073 Generic Code (Multiple Manufacturers) Cyclophosphamide Injection, cyclophosphamide (dr. reddy's), 5 mg
J9074 Sandoz Cyclophosphamide Injection, cyclophosphamide (sandoz), 5 mg
J9075 Generic Code (Multiple Manufacturers) Cyclophosphamide Injection, cyclophosphamide, not otherwise specified, 5 mg
J9076 Log in to view
Log in to view all 6 505(b)(2) codes

Cyclophosphamide CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Cyclophosphamide (J9071) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9071. Wastage billing guide →

Cyclophosphamide Medically Unlikely Edits (MUE)

The most billing units of J9071 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg.

Practitioner Office & Hospital Outpatient
1,500 units / day
= 7,500 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

Cyclophosphamide Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

acute lymphoblastic (stem-cell) leukemia acute myelogenous and monocytic leukemia adenocarcinoma of the ovary carcinoma of the breast chronic granulocytic leukemia chronic lymphocytic leukemia malignant lymphomas multiple myeloma mycosis fungoides neuroblastoma retinoblastoma

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Cyclophosphamide billing and coding guide?
Billing and coding information for Cyclophosphamide can be found through Eugia US. Visit Here →
Are there any available Cyclophosphamide patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for Cyclophosphamide.
Where can I find Cyclophosphamide prescribing information?
Cyclophosphamide prescribing information can be found at the link below: Visit Here →
Where can I find Cyclophosphamide side effect information?
Information regarding Cyclophosphamide's side effects can be found at MedlinePlus Visit Here →
Does billing Cyclophosphamide require JZ/JW wastage modifiers?
CMS does not include Cyclophosphamide (J9071) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9071. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.